SEGMENT INFORMATION

12 Months Ended

Mar. 30, 2013

Segment Reporting [Abstract]

SEGMENT INFORMATION

SEGMENT INFORMATION

Segment Definition Criteria

We manage our business on the basis of one operating segment: the design, manufacture, and marketing of blood management solutions. Our chief operating decision-maker uses consolidated results to make operating and strategic decisions. Manufacturing processes, as well as the regulatory environment in which we operate, are largely the same for all product categories.

Enterprise Wide Disclosures About Product and Services

We have four global product families: plasma, blood center, hospital, and software solutions.

Our products include whole blood disposables, equipment devices and the related disposables used with these devices. Disposables include part of plasma, blood center, and hospital product families. Plasma consists of the disposables used to perform apheresis for the separation of whole blood components and subsequent collection of plasma to be used as a raw material for biologically derived pharmaceuticals. Blood center consists of disposables which separate whole blood for the subsequent collection of platelets, plasma, red cells, or a combination of these components for transfusion to patients as well as disposables for manual whole blood collection. Hospital consists of surgical disposables (principally the Cell Saver^® autologous blood recovery system targeted to procedures that involve rapid, high volume blood loss such as cardiovascular surgeries and the cardioPAT^® cardiovascular perioperative autotransfusion system designed to remain with the patient following surgery to recover blood and the patient’s red cells to prepare them for reinfusion), the OrthoPAT^® orthopedic perioperative autotransfusion system designed to operate both during and after surgery to recover and wash the patient’s red cells to prepare them for reinfusion, and diagnostics products (principally the TEG^® Thrombelastograph^® hemostasis analyzer used to help assess a surgical patient’s hemostasis during and after surgery).

Software solutions include information technology platforms that assist blood centers, plasma centers, and hospitals to more effectively manage regulatory compliance and operational efficiency.

Revenues from External Customers:

(In thousands)	March 30, 2013		March 31, 2012		April 2, 2011
Disposable revenues
Plasma disposables	$	268,900	$	258,061	$	227,209
Blood center disposables
Platelet	169,602		167,946		156,251
Red cell	49,733		48,034		46,828
Whole blood	138,436		—		—
	357,771		215,980		203,079
Hospital disposables
Surgical	73,508		66,619		66,503
OrthoPAT	30,230		31,186		35,631
Diagnostics	27,356		23,087		19,414
	131,094		120,892		121,548
Disposables revenue	757,765		594,933		551,836
Software solutions	69,952		70,557		66,876
Equipment & other	64,273		62,354		57,982
Total revenues	$	891,990	$	727,844	$	676,694

Enterprise Wide Disclosures About Product and Services

Year Ended (in thousands)

March 30, 2013	United States		Other North America		Total North America		Japan		Other Asia		Total Europe		Total Consolidated
Sales	$	454,874	$	6,851	$	461,725	$	120,726	$	84,860	$	224,679	$	891,990
Total Assets	$	830,754	$	225,849	$	1,056,603	$	44,189	$	41,037	$	320,088	$	1,461,917
Long-Lived Assets	$	503,606	$	209,439	$	713,045	$	12,977	$	8,076	$	117,717	$	851,815

March 31, 2012	United States		Other North America		Total North America		Japan		Other Asia		Total Europe		Total Consolidated
Sales	$	352,160	$	512	$	352,672	$	124,381	$	67,223	$	183,568	$	727,844
Total Assets	$	634,171	$	15,365	$	649,536	$	50,509	$	27,353	$	183,737	$	911,135
Long-Lived Assets	$	305,370	$	12,796	$	318,166	$	13,128	$	3,961	$	38,009	$	373,264

April 2, 2011	United States		Other North America		Total North America		Japan		Other Asia		Total Europe		Total Consolidated
Sales	$	316,447	$	908	$	317,355	$	110,263	$	61,594	$	187,482	$	676,694
Total Assets	$	582,733	$	15,903	$	598,636	$	47,156	$	18,164	$	169,308	$	833,264
Long-Lived Assets	$	305,305	$	12,715	$	318,020	$	12,391	$	4,181	$	38,092	$	372,684

The Long-Lived Assets reported above include Goodwill, Intangibles and Net Property, Plant and Equipment.